← Back to all trials
Recruiting
NCT05288790
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Conditions: Microtia, Dysbiosis, Alcohol Drinking, HIV Infections, Cardiovascular Diseases
Sex: All
Ages: 18 Years – 89 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 250
Sponsor: Vanderbilt University Medical Center
Location: Vanderbilt University Medical Center Nashville Tennessee
Summary
Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria in your gut and these changes increase the risk of heart disease and death. This randomized controlled trial will determine whether a pill containing healthy gut bacteria can increase the number good bacteria in the gut, lower levels of inflammation, and lower the risk of heart disease and death.
Eligibility Criteria
Inclusion Criteria:
* HIV infected
Exclusion Criteria:
* Not fluent in English
Source: ClinicalTrials.gov (NCT05288790). StuddyBuddy aggregates publicly available trial information.
